Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Giant Biogene Holding CoHKSE:02367 +1.24%85 Quick Ratio is 10.79 as of Dec. 2025, which is 48% above its 10-year median of 7.29. GuruFocus rates HKSE:02367 with a GF Score™ of 85/100 and a GF Value™ of HK$68.03 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 2,009 Consumer Packaged Goods companies, Giant Biogene Holding Co ranks better than 96.96% on this metric.
Giant Biogene Holding Co has a quick ratio of 10.79. It generally indicates good short-term financial strength.
The historical rank and industry rank for Giant Biogene Holding Co's Quick Ratio or its related term are showing as below:
HKSE:02367'
s Quick Ratio Range Over the Past 10 Years
Min: 1.02 Med: 7.29 Max: 10.78
Current: 10.18
During the past 7 years, Giant Biogene Holding Co's highest Quick Ratio was 10.78. The lowest was 1.02. And the median was 7.29.
HKSE:02367's Quick Ratio is ranked better than 96.96% of 2009
companies
in the Consumer Packaged Goods industry
Industry Median: 1.05
vs HKSE:02367: 10.18
Giant Biogene Holding Co (HKSE:02367) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Giant Biogene Holding Co Quick Ratio Related Terms
Giant Biogene Holding Co Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Giant Biogene Holding Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Giant Biogene Holding Co Quick Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Giant Biogene Holding Co's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Giant Biogene Holding Co's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Giant Biogene Holding Co (HKSE:02367) has a Quick Ratio of 10.79 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Giant Biogene Holding Co and its competitors. This is 48% above median its historical median of 7.29. Over the past decade, Giant Biogene Holding Co's Quick Ratio has ranged from 1.02 to 10.78. According to the industry distribution chart, Giant Biogene Holding Co ranks #61 out of 2009 companies in the Consumer Packaged Goods industry, placing it in the top 3%.
Is Giant Biogene Holding Co's Quick Ratio too high?
Giant Biogene Holding Co's current Quick Ratio of 10.79 is 48% above median its 10-year median of 7.29. Over the past 10 years, this metric has ranged from a low of 1.02 to a high of 10.78. The Consumer Packaged Goods industry median Quick Ratio is 1.05. Giant Biogene Holding Co's value of 10.79 is 927.6% above this industry median. Based on the distribution chart, Giant Biogene Holding Co ranks #61 out of 2009 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Giant Biogene Holding Co has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Giant Biogene Holding Co's Quick Ratio compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Giant Biogene Holding Co ranks #61 out of 2009 companies for Quick Ratio. This places Giant Biogene Holding Co in the top 3% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.05. Giant Biogene Holding Co's value of 10.79 is 927.6% above this benchmark. Historically, Giant Biogene Holding Co's own Quick Ratio has ranged from 1.02 to 10.78 over the past decade. While the company's 10-year median is 7.29 vs. the industry median of 1.05, Giant Biogene Holding Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Consumer Packaged Goods company?
The median Quick Ratio among Consumer Packaged Goods companies is 1.05, based on 2,009 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Giant Biogene Holding Co's current Quick Ratio of 10.79 is 927.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Giant Biogene Holding Co and its competitors. For the Consumer Packaged Goods industry, the median Quick Ratio is 1.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Giant Biogene Holding Co's current Quick Ratio is 10.79, which is 48% above median its own 10-year median of 7.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Giant Biogene Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Giant Biogene Holding Co (HKSE:02367) is currently considered Possible Value Trap. The stock's GF Value™ is HK$68.03, compared to a current price of HK$24.46 — trading 64% below its estimated fair value. The current Quick Ratio is 10.79, which is 48% above median its 10-year median of 7.29 and 927.6% above the Consumer Packaged Goods industry median of 1.05. Giant Biogene Holding Co's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Giant Biogene Holding Co (HKSE:02367), the current Quick Ratio is 10.79 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Giant Biogene Holding Co (HKSE:02367) Overvalued in 2026?
Based on GuruFocus' analysis, Giant Biogene Holding Co stock appears to be undervalued.
The current stock price of HK$24.46 is trading 64% below its estimated GF Value™ of HK$68.03.
GuruFocus considers Giant Biogene Holding Co to be Possible Value Trap.
Key valuation signals for HKSE:02367:
Quick Ratio: 10.79 (48% above median its 10-year median of 7.29)
GF Value™: HK$68.03 vs. price of HK$24.46 (64% below fair value)
Industry Position: 927.6% above the Consumer Packaged Goods median (#61 of 2009)
No single metric tells the full story. See the HKSE:02367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Giant Biogene Holding Co Ltd designs, develops, and manufactures professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenoside technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop & manufacture multiple types of recombinant collagen & rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty & health properties such as skin repair, anti-aging, whitening, moisturizing, & immunity improvement, with a broad range of applications in the beauty & health sectors. The group is organised into a single business unit that mainly includes the research, development, manufacture, & sale of bioactive material-based beauty & health products.
85GF Score
Get the complete analysis for HKSE:02367
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02367 has been successfully added to your 
